Cargando…

Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes

Detalles Bibliográficos
Autores principales:	Hirsch, Irl B., Sherr, Jennifer L., Hood, Korey K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2019
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973546/ https://www.ncbi.nlm.nih.gov/pubmed/30787056 http://dx.doi.org/10.2337/dci18-0040

Ejemplares similares

Connecting the Dots Among Science, Education, and STEM
por: Nazir, Joanne
Publicado: (2022)

Real-Time Continuous Glucose Monitoring During the Coronavirus Disease 2019 Pandemic and Its Impact on Time in Range
por: van der Linden, Joost, et al.
Publicado: (2021)

Experimental status epilepticus, COX‐2 and BDNF: Connecting the dots
por: Marchi, Nicola
Publicado: (2021)

Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease
por: Navaneethan, Sankar D., et al.
Publicado: (2017)

Interventions With Adherence-Promoting Components in Pediatric Type 1 Diabetes: Meta-analysis of their impact on glycemic control
por: Hood, Korey K., et al.
Publicado: (2010)

Metabolic Disease, NAD Metabolism, Nicotinamide Riboside, and the Gut Microbiome: Connecting the Dots from the Gut to Physiology
por: Sauve, Anthony A.
Publicado: (2022)

On space-time metrics inducing the radiation connection
por: Burdet, G, et al.
Publicado: (1993)

Matrix Gla-Protein (MGP) Not Only Inhibits Calcification in Large Arteries But Also May Be Renoprotective: Connecting the Dots
por: Epstein, Murray
Publicado: (2016)

Does Time-in-Range Matter? Perspectives From People With Diabetes on the Success of Current Therapies and the Drivers of Improved Outcomes
por: Runge, Ava S., et al.
Publicado: (2018)

Brain microvascular disease and functional network connectivity—a call for a stage-based approach
por: Schreiber, Stefanie, et al.
Publicado: (2023)

The Prognostic Value of Time in Range in Type 2 Diabetes
por: Selvin, Elizabeth
Publicado: (2021)

Commentary to: a cross-validation-based approach for delimiting reliable home range estimates
por: Dougherty, Eric R., et al.
Publicado: (2018)

Microvascular Contributions to Insulin Resistance
por: Rattigan, Stephen, et al.
Publicado: (2013)

Fitting K(V) potassium channels into the PIP(2) puzzle: Hille group connects dots between illustrious HH groups
por: Hilgemann, Donald W.
Publicado: (2012)

Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease
por: Mayeda, Laura, et al.
Publicado: (2020)

Jot: guiding journal selection with suitability metrics
por: Gaffney, Stephen G., et al.
Publicado: (2022)

Comment on “The power metric: a new statistically robust enrichment-type metric for virtual screening applications with early recovery capability”
por: Šícho, M., et al.
Publicado: (2018)

Is cognitive impairment the fourth diabetic microvascular complication?
por: Kawamura, Takahiko, et al.
Publicado: (2011)

HIV prevention metrics: lessons to be learned from contraception
por: Pyra, Maria, et al.
Publicado: (2022)

Mineralocorticoid Receptors: An Appealing Target to Treat Coronary Microvascular Dysfunction in Diabetes
por: Bender, Shawn B., et al.
Publicado: (2015)

Connecting the dots
por: Carta, Antonio
Publicado: (2017)

Connecting the Dots
por: Collective
Publicado: (2016)

Linking Coronary Microvascular and Cardiac Diastolic Dysfunction in Diabetes: Are Women More Vulnerable?
por: Bender, Shawn B.
Publicado: (2019)

Nitric oxide, leukocytes and microvascular permeability: causality or bystanders?
por: Hauser, Balázs, et al.
Publicado: (2008)

Contribution of sex hormones in the progression of diabetic microvascular diseases
por: Jia, Weiping
Publicado: (2012)

Clinical Implications of Coronary Microvascular Dysfunction in Patients with CKD
por: Elbaum, Lindsay, et al.
Publicado: (2022)

Towards a guideline for evaluation metrics in medical image segmentation
por: Müller, Dominik, et al.
Publicado: (2022)

Reply to the comment made by Šicho, Vorśilák and Svozil on ‘The Power metric: a new statistically robust enrichment-type metric for virtual screening applications with early recovery capability’
por: De Winter, Hans, et al.
Publicado: (2018)

Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review
por: Jacobsen, Laura M., et al.
Publicado: (2023)

Home Blood Glucose Monitoring in Type 2 Diabetes: Broken health care system undermines study's impact
por: Hirsch, Irl B.
Publicado: (2011)

Insulin in America: A Right or a Privilege?
por: Hirsch, Irl B.
Publicado: (2016)

Ex Vivo Metrics™, a preclinical tool in new drug development
por: Curtis, C Gerald, et al.
Publicado: (2008)

Using the Taxonomy and the Metrics: What to Study When and Why: Comment on "Metrics and Evaluation Tools for Patient Engagement in Healthcare Organization- and System-Level Decision-Making: A Systematic Review"
por: Sofaer, Shoshanna
Publicado: (2018)

Commentary: Hyperreflective dots - An imaging biomarker of inflammation?
por: Agarwal, Aniruddha
Publicado: (2019)

Carbon dots for the treatment of cancer-related anemia
por: Han, Xu, et al.
Publicado: (2022)

Connecting the dots from east to west
por: Kelley, Keith W., et al.
Publicado: (2022)

Hidden gems: a pilot project to solicit and reward patients’ and caregivers’ ideas for research
por: Moxham, Freya, et al.
Publicado: (2023)

Effect of Liraglutide on Times in Glycaemic Ranges as Assessed by CGM for Type 2 Diabetes Patients Treated With Multiple Daily Insulin Injections
por: Sofizadeh, Sheyda, et al.
Publicado: (2019)

S-nitrosation of proteins: An emergent regulatory mechanism in microvascular permeability and vascular function
por: Sánchez, Fabiola A., et al.
Publicado: (2013)

Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
por: Murphy, Helen R.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_lv5klde7gcpedn3cvevghap0lr